In laryngopharyngeal reflux (LPR), refluxed stomach contents travel up the oesophagus and reach the larynx, causing chronic extra-gastrointestinal symptoms such as a persistent cough, hoarseness or difficulty swallowing, meaning it is often attributed to ENT problems. Rapid diagnosis in primary care is key to timely and appropriate treatment, helping to avoid chronic injury and even reducing the risk of cancer.
Peptest from BIOHIT HealthCare Ltd is a non-invasive diagnostic test for the identification of LPR based on lateral flow technology. It uses the quantitative analysis of stomach-derived pepsin in samples from the upper digestive and respiratory tracts to quickly and conclusively confirm the occurrence and severity of reflux. Peptest could play a key role in streamlining the assessment of symptomatic patients and in monitoring disease progression for optimal ongoing treatment, significantly minimising waiting times for more invasive investigations and alleviating the burden on the healthcare system.
FURTHER INFORMATION:
Learn more about Peptest here:
www.biohithealthcare.co.uk/biohit-product/peptest
